Pune, India -- (SBWIRE) -- 04/30/2019 -- According to a new report published by Reports Monitor titled, "Global Yeast Infection Market, Growth Opportunities, Innovations and Forecast, 2018-2025," the Yeast Infection Market is projected to grow rapidly from 2018 to 2025.
Yeast infection is caused by different types of yeast out of which candida albicans is most common type. Yeast normally present on the skin, in vagina and intestine, which can be responsible for infection if immune response is weak, hygiene not maintain and prolonged use of antibiotic.
People suffering from obesity, hypothyroidism, inflammatory disorders, autoimmune disease and diabetes are more incline to have yeast infection. Major drivers of yeast infection market are continuous rising geriatric population, increasing number of HIV patient and incidence of autoimmune diseases. According to the joint United Nations programme on HIV and AIDS, by the end of 2015, 36 million peoples are suffering from HIV/AIDS.
Request a Sample Copy @ https://goo.gl/5Ks2dG
The report provides a detailed analysis of yeast infection market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter's analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.
The global yeast infection market is majorly segmented on the basis of pathogens, types and treatment. On the basis of pathogens, the market is segmented into candida glabrata, candida albicans, candida rugosa and others. Based on the type the market is segmented into vaginal yeast infection, throat yeast infection, skin yeast infection and others. Based on the treatment the market is segmented into drug treatment and surgery.
The global Dehumidifier market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). As per the data from autoimmune registry, approximately 12 million Americans were suffering from the auto immune disease in 2012. Growth in the Europe is attributed by skilled medical professional and availability of advanced treatment facilities. Increasing population, developing healthcare infrastructure and disposal income in developing countries of Asia-Pacific contribute to the growth of this market.
The major key players operating in the market are: Astellas, Merck & Co., Inc., Abbott laboratories, Synmedic Laboratories, Sanofi, Astra Zeneca, Novartis, Allergan and Pfizer.
The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales.
View Full Report Description with TOC: https://goo.gl/kiSuWm
Our analyst implement several qualitative tools such as Ansoff's Matrix, PESTEL analysis, Porter's five force analysis among other to interpret and represent key industry findings.
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.
Some Points from TOC:
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter's Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016
3.6. Market Overview
4. Pathogens Overview
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Candida Glabrata
4.2.2. Candida Albicans
4.2.3. Candida Rugosa
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
View Full Press Release: https://garnerinsights.com/press-release/yeast-infection-market